Application of ectoine and derivatives thereof in preparing medicament for preventing and treating digestive tract diseases caused by chemotherapy medicaments
A technology of ectoine and chemotherapy drugs, applied in the field of ectoine and its derivatives in the field of medicine, can solve problems such as damage to the digestive tract mucosal system, and achieve a wide range of therapeutic effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0024] Example 1 1,4,5,6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acid and 1,4,5,6-tetrahydro-2-methyl-5-hydroxyl-4-pyrimidinecarboxylic acid Therapeutic effect on oral mucositis induced by chemotherapeutic drugs
[0025] Kunming mice, half male and half female, 18-28g, 6-8 weeks old, were housed in separate cages at room temperature in the animal room, and the quarantine period was 5 days. Dissolve methotrexate in normal saline, and after disinfecting the abdominal skin of mice, give methotrexate normal saline solution by intraperitoneal injection, once a day, the dose is 1.5 mg / mouse, and the administration is continuous for 3-5 days.
[0026] 30 mice with successful modeling were given intravenous injection of normal saline (NS), 1,4,5,6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acid saline solution (Ect, calculated as Ect , the dosage is 1.0mg / ml), 1,4,5,6-tetrahydro-2-methyl-5-hydroxyl-4-pyrimidinecarboxylic acid physiological saline solution (in terms of Ect-OH, the ...
Embodiment 2
[0032] Example 2 1,4,5,6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acid and 1,4,5,6-tetrahydro-2-methyl-5-hydroxyl-4-pyrimidinecarboxylic acid Therapeutic effect on small intestinal mucositis induced by chemotherapeutic drugs
[0033] Balb / C mice, 2-3 weeks old. Mix 5-Fu and irinotecan at a ratio of 1:1 and dissolve in appropriate amount of normal saline, and give 5-Fu and irinotecan intravenously at a dose of 100 mg / kg 5-Fu on the 1st, 2nd and 3rd day respectively. of physiological saline solution.
[0034] 30 rats with successful modeling were given intravenous injection of normal saline (NS), 1,4,5,6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acid saline solution (Ect, calculated as Ect, The dosage is 1.0 mg / ml), 1,4,5,6-tetrahydro-2-methyl-5-hydroxyl-4-pyrimidinecarboxylic acid physiological saline solution (in Ect-OH, the dosage is 2.0 mg / ml), amifostine normal saline solution (calculated as amifostine, the dosage is 2.0mg / ml) and interleukin 1 (IL-1, calculated as IL...
Embodiment 3
[0039] Example 3 Preparation of 1,4,5,6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acid tablets
[0040] The formula is as follows:
[0041]
[0042] Pass the prescribed 1,4,5,6-tetrahydro-2-methyl-4-pyrimidine carboxylic acid through a 150 μm sieve, and pass the excipients through a 180 μm sieve for use; now the 1,4,5,6-tetrahydro-2-methyl Base-4-pyrimidine carboxylic acid is mixed with microcrystalline cellulose, and then mixed successively with lactose, sodium carboxymethyl starch, polyvinylpyrrolidone, and magnesium stearate, and then pressed into tablets after mixing evenly.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com